Haefeli WE - Search Results

1

Quantitative bile acid profiling by liquid chromatography quadrupole time-of-flight mass spectrometry: monitoring hepatitis B therapy by a novel Na(+)-taurocholate cotransporting polypeptide inhibitor.

Haag M, Hofmann U, Mürdter TE, Heinkele G, Leuthold P, Blank A, Haefeli WE, Alexandrov A, Urban S, Schwab M. Haag M, et al. Among authors: haefeli we. Anal Bioanal Chem. 2015 Sep;407(22):6815-25. doi: 10.1007/s00216-015-8853-5. Epub 2015 Jul 5. Anal Bioanal Chem. 2015. PMID: 26143062

2

Simultaneous determination of hypericin and hyperforin in human plasma with liquid chromatography-tandem mass spectrometry.

Riedel KD, Rieger K, Martin-Facklam M, Mikus G, Haefeli WE, Burhenne J. Riedel KD, et al. Among authors: haefeli we. J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Dec 25;813(1-2):27-33. doi: 10.1016/j.jchromb.2004.09.061. J Chromatogr B Analyt Technol Biomed Life Sci. 2004. PMID: 15556512

3

A systematic comparison of four different workup procedures for systematic toxicological analysis of urine samples using gas chromatography-mass spectrometry.

Peters FT, Drvarov O, Lottner S, Spellmeier A, Rieger K, Haefeli WE, Maurer HH. Peters FT, et al. Among authors: haefeli we. Anal Bioanal Chem. 2009 Jan;393(2):735-45. doi: 10.1007/s00216-008-2471-4. Epub 2008 Oct 31. Anal Bioanal Chem. 2009. PMID: 18974980

4

Efavirenz treatment and false-positive results in benzodiazepine screening tests.

Blank A, Hellstern V, Schuster D, Hartmann M, Matthée AK, Burhenne J, Haefeli WE, Mikus G. Blank A, et al. Among authors: haefeli we. Clin Infect Dis. 2009 Jun 15;48(12):1787-9. doi: 10.1086/599109. Clin Infect Dis. 2009. PMID: 19432553

5

Quantification of femtomolar concentrations of the CYP3A substrate midazolam and its main metabolite 1'-hydroxymidazolam in human plasma using ultra performance liquid chromatography coupled to tandem mass spectrometry.

Burhenne J, Halama B, Maurer M, Riedel KD, Hohmann N, Mikus G, Haefeli WE. Burhenne J, et al. Among authors: haefeli we. Anal Bioanal Chem. 2012 Mar;402(7):2439-50. doi: 10.1007/s00216-011-5675-y. Epub 2012 Jan 15. Anal Bioanal Chem. 2012. PMID: 22252655

6

Health workers' knowledge of and attitudes towards computer applications in rural African health facilities.

Sukums F, Mensah N, Mpembeni R, Kaltschmidt J, Haefeli WE, Blank A. Sukums F, et al. Among authors: haefeli we. Glob Health Action. 2014 Oct 27;7:24534. doi: 10.3402/gha.v7.24534. eCollection 2014. Glob Health Action. 2014. PMID: 25361721 Free PMC article.

7

Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study.

Bogomolov P, Alexandrov A, Voronkova N, Macievich M, Kokina K, Petrachenkova M, Lehr T, Lempp FA, Wedemeyer H, Haag M, Schwab M, Haefeli WE, Blank A, Urban S. Bogomolov P, et al. Among authors: haefeli we. J Hepatol. 2016 Sep;65(3):490-8. doi: 10.1016/j.jhep.2016.04.016. Epub 2016 Apr 27. J Hepatol. 2016. PMID: 27132170 Clinical Trial.

8

First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B.

Blank A, Markert C, Hohmann N, Carls A, Mikus G, Lehr T, Alexandrov A, Haag M, Schwab M, Urban S, Haefeli WE. Blank A, et al. Among authors: haefeli we. J Hepatol. 2016 Sep;65(3):483-9. doi: 10.1016/j.jhep.2016.04.013. Epub 2016 Apr 27. J Hepatol. 2016. PMID: 27132172

9

Autoinhibitory properties of the parent but not of the N-oxide metabolite contribute to infusion rate-dependent voriconazole pharmacokinetics.

Hohmann N, Kreuter R, Blank A, Weiss J, Burhenne J, Haefeli WE, Mikus G. Hohmann N, et al. Among authors: haefeli we. Br J Clin Pharmacol. 2017 Sep;83(9):1954-1965. doi: 10.1111/bcp.13297. Epub 2017 May 18. Br J Clin Pharmacol. 2017. PMID: 28370390 Free PMC article.

10

The NTCP-inhibitor Myrcludex B: Effects on Bile Acid Disposition and Tenofovir Pharmacokinetics.

Blank A, Eidam A, Haag M, Hohmann N, Burhenne J, Schwab M, van de Graaf S, Meyer MR, Maurer HH, Meier K, Weiss J, Bruckner T, Alexandrov A, Urban S, Mikus G, Haefeli WE. Blank A, et al. Among authors: haefeli we. Clin Pharmacol Ther. 2018 Feb;103(2):341-348. doi: 10.1002/cpt.744. Epub 2017 Jun 21. Clin Pharmacol Ther. 2018. PMID: 28543042 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

586 results

Search Page

Filters